Publications by authors named "H Piechuta"

Claim this Profile
D
Discovery of a potent and selective prostaglandin D2 receptor antagonist, [(3R)-4-(4-chloro-benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic acid (MK-0524).
Claudio F Sturino, Gary O'Neill, Nicolas Lachance, Michael Boyd, Carl Berthelette, Hana Piechuta

J Med Chem· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of L-791,943: a potent, selective, non emetic and orally active phosphodiesterase-4 inhibitor.
Daniel Guay, Pierre Hamel, Marc Blouin, Christine Brideau, Chi Chung Chan, Hanna Piechuta

Bioorg Med Chem Lett· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substituted indoles as potent and orally active 5-lipoxygenase activating protein (FLAP) inhibitors.
R Frenette, J H Hutchinson, S Léger, M Thérien, C Brideau, H Piechuta

Bioorg Med Chem Lett· August 1999

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of a selective phosphodiesterase IV inhibitor (CDP-840) in a leukotriene-dependent non-human primate model of allergic asthma.
T R Jones, M McAuliffe, C S McFarlane, H Piechuta, D Macdonald

Can J Physiol Pharmacol· February 1998

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substituted (pyridylmethoxy)naphthalenes as potent and orally active 5-lipoxygenase inhibitors; synthesis, biological profile, and pharmacokinetics of L-739,010.
P Hamel, D Riendeau, C Brideau, C C Chan, S Desmarais, H Piechuta

J Med Chem· August 1997

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis